Do you find that keeping abreast of the latest publications is a real challenge?
Time just isn’t on your side? Help is at hand with Journal Update! The CDWG keeps a careful watch on the latest publications and our Steering Committee selects 6 to 8 of the key “must-see” papers to feature on each update of the website.
The key points of each paper are summarized for you, and a leading authority in the relevant field is invited to provide an expert commentary on the overall value of the paper – the methodologies used, the endpoints measured and the clinical utility of the results in day-to-day practice.
There are downloadable slides illustrating the key points, which we hope you may find useful for teaching purposes.
Section Five
This Section is eligible for 1.0 AMA PRA Category 1 Credit(s). Please read all articles in the section before applying for CME credits.
- A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's strictures
East JE, Brooker JC, Rutter MD, Saunders BP. - The incidence of arterial thromboembolic diseases in inflammatory bowel disease: A population-based study
Bernstein CN, Wajda A, Blanchard JF. - Gender differences in presentation and course of disease in pediatric patients with Crohn's disease.
Gupta N, Bostrom AG, Kirschner BS, et al. - Laparoscopy or conventional open surgery for patients with ileocolonic Crohn's disease? A prospective study
Fichera A, Peng SL, Elisseou NM, et al. - Mortality by medication use among patients with inflammatory bowel disease, 1996–2003
Hutfless SM, Weng X, Lui L, et al. - Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU)
Mehdizadeh S, Chen G, Enayati PJ, et al.
Section Six
This Section is eligible for 1.0 AMA PRA Category 1 Credit(s). Please read all articles in the section before applying for CME credits.
- A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch–anal anastomosis
Fleshner P, Ippoliti A, Dubinsky M, et al. - Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: An open randomised trial
D’Haens G, Baert F, van Assche G, et al. - High frequency of early colorectal cancer in inflammatory bowel disease
Lutgens MW, Vleggaar FP, Schipper MEI, et al. - Higher incidence of abnormal Pap smears in women with inflammatory bowel disease
Kane S, Khatibi B, Reddy D. - Rosiglitazone for active ulcerative colitis: A randomized placebo-controlled trial
Lewis JD, Lichtenstein GR, Deren JJ, et al; Rosiglitazone for Ulcerative Colitis Study Group.
